Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07642050 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study to Determine if BHV-1400 is Effective and Safe in Adults With IgA Nephropathy

StatusNot Yet Recruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
The purpose of this study is to determine if BHV-1400 is effective and safe in the treatment of IgA Nephropathy. Participants will be randomized in a 2:1 ratio to receive either BHV-1400 or placebo.
Trial Details
NCT Number NCT07642050
Lead Sponsor Biohaven Therapeutics Ltd.
Conditions
(from sponsor)		 IgA Nephropathy
Related terms Glomerulonephritis, Glomerulonephritis, IGA, Kidney Diseases, Nephritis, Proteinuria, Renal Insufficiency, Chronic, Urologic Diseases
Enrollment 420 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov